O
OrbiMed’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,914,479
| Closed | -$10.2M | – | 113 |
|
|
2023
Q3 | $10.2M | Hold |
1,914,479
| – | – | 0.22% | 82 |
|
|
2023
Q2 | $18.2M | Hold |
1,914,479
| – | – | 0.33% | 72 |
|
|
2023
Q1 | $21.1M | Sell |
1,914,479
-545,629
| -22% | -$6M | 0.41% | 64 |
|
|
2022
Q4 | $36.4M | Sell |
2,460,108
-339,892
| -12% | -$5.03M | 0.7% | 52 |
|
|
2022
Q3 | $53.5K | Sell |
2,800,000
-1,981,646
| -41% | -$37.9K | 0.99% | 36 |
|
|
2022
Q2 | $102K | Sell |
4,781,646
-1,292,204
| -21% | -$27.5K | 1.85% | 19 |
|
|
2022
Q1 | $117M | Hold |
6,073,850
| – | – | 1.9% | 18 |
|
|
2021
Q4 | $126M | Hold |
6,073,850
| – | – | 1.62% | 20 |
|
|
2021
Q3 | $145M | Hold |
6,073,850
| – | – | 1.59% | 19 |
|
|
2021
Q2 | $166M | Hold |
6,073,850
| – | – | 1.68% | 16 |
|
|
2021
Q1 | $176M | Hold |
6,073,850
| – | – | 1.64% | 17 |
|
|
2020
Q4 | $171M | Buy |
6,073,850
+1,400,000
| +30% | +$39.4M | 1.5% | 17 |
|
|
2020
Q3 | $137M | Hold |
4,673,850
| – | – | 1.72% | 17 |
|
|
2020
Q2 | $141M | Hold |
4,673,850
| – | – | 1.99% | 19 |
|
|
2020
Q1 | $139M | Buy |
+4,673,850
| New | +$139M | 2.34% | 12 |
|